Intravenous Propofol and Fentanyl vs Propofol for Sedation in TRUS Biopsy

Sponsor
Mahidol University (Other)
Overall Status
Completed
CT.gov ID
NCT02733705
Collaborator
(none)
124
1
2
16.9
7.3

Study Details

Study Description

Brief Summary

Nowadays, TRUS biopsy become one of the most popular tests for diagnosis of prostate cancer. This procedure causes pain to the patients who does not received the sedative drugs or analgesic drugs. There are many ways to reduce pain and inconvenience for the patients, such as intravenous propofol, intravenous fentanyl etc. In Siriraj hospital, anesthesiologists usually give intravenous propofol with intravenous opioids but the visual analogue score after this procedure was average at 0.9-2.9. Furthermore, some systematic reviews have shown that there was no difference in pain score between periprostatic nerve block plus opioid and periprostatic nerve block only. So, this study is to find out whether opioids is need for TRUS biopsy.

Condition or Disease Intervention/Treatment Phase
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
124 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomised Controlled Trial Comparing Combined Intravenous Propofol and Fentanyl Versus Intravenous Propofol Alone for Sedation in Patients Undergoing Transrectal Ultrasound-guided (TRUS) Prostate Biopsy
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
May 31, 2018
Actual Study Completion Date :
May 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Control

normal saline IV plus propofol infusion

Other: Control
normal saline IV

Drug: propofol
propofol infusion

Active Comparator: Fentanyl

0.5 mcg/kg ideal body weight IV plus propofol infusion

Drug: Fentanyl
fentanyl 0.5 mcg/kg ideal BW

Drug: propofol
propofol infusion

Outcome Measures

Primary Outcome Measures

  1. Pain assess using Numeric rating scale (NRS) score [20 minutes]

Secondary Outcome Measures

  1. Number of participants with hypoxia defined as oxygen saturation <92% [60 minutes]

    The investigators define hypoxia as oxygen saturation < 92%. The investigators will report as number of episode.

  2. Number of participants with hypotension, defined as systolic blood pressure <90 mmHg [60 minutes]

    The investigators define hypotension as systolic blood pressure< 90 mmHg. The investigators will report as number of episode.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age over 18 year

  • Patient American society of anesthesiology physical status I-III.

  • Scheduled for Transrectal ultrasound-guided prostate biopsy

  • BMI equal to or less than 30 kg/cm2

Exclusion Criteria:
  • Known hypersensitivity to propofol or fentanyl

  • History of bleeding tendency

  • Known case of active anal or rectal disease

  • Unable to rate pain score

  • History of drug abuse

  • Chronic opioid use

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sirilak Suksompong Bangkok Thailand 10700

Sponsors and Collaborators

  • Mahidol University

Investigators

  • Principal Investigator: Sirilak Suksompong, Mahidol University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sirilak Suksompong, Associate Professor, Mahidol University
ClinicalTrials.gov Identifier:
NCT02733705
Other Study ID Numbers:
  • TRUS
First Posted:
Apr 11, 2016
Last Update Posted:
Sep 1, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Sirilak Suksompong, Associate Professor, Mahidol University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 1, 2021